相关实验视频

Updated: Sep 18, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

在固体瘤中单独复合的多腔 vs. 标准化的腹腔营养袋-一项随机临床试验 (IKF-010)

Thorsten Oliver Goetze1, Ralf-Dieter Hofheinz2, Ingeborg Roetzer3

  • 1Hospital Northwest, University Cancer Center Frankfurt, Frankfurt, Germany; The Frankfurt Institute of Clinical Cancer Research IKF GmbH, Frankfurt, Germany.

Clinical nutrition ESPEN
|June 26, 2025
PubMed

Insights

与传统的袋子相比,用于家庭亲肠道营养 (HPN) 的多腔袋 (MCB) 显著改善了患者的自主性,并减少了不良事件. 这种方法提高了接受HPN的癌症患者的自我管理.

科学领域:

  • 在瘤学瘤学.
  • 临床营养学 临床营养学
  • 患者护理 患者护理

背景情况:

  • 癌症患者往往需要在家中进行亲肠道营养 (HPN),造成感染和依赖护理的风险.
  • 多腔袋 (MCB) 为个性化HPN提供了一个潜在的解决方案,旨在减少处理,提高患者自主性和降低感染风险.

研究的目的:

  • 为了比较使用MCB单独组合的HPN的疗效和安全性,与传统的2/3腔袋相比.
  • 评估对患者自主权,导管相关感染 (CRI) 和癌症患者整体安全性的影响.

主要方法:

  • 一项随机对照试验 (IKF-t01/PEKANNUSS) 将基于MCB的HPN (A臂) 与晚期瘤患者的传统HPN (B臂) 进行比较.
  • 主要终点:自主性率 (HPN≥70%的自我管理). 二级终点:CRIs,安全性,体重和白蛋白水平.

主要成果:

  • 患者自主性显著增加MCB (52%对33%,p=0.04),特别是在ECOG≤1 (68%对42%) 的患者中.
  • MCB显著降低了家庭添加剂注射的需要 (11%对96%,p<0.01) 和与HPN相关的整体不良事件 (27%对55%,p<0.01).
  • 使用MCB观察到数量较低的CRI率 (13%对22%),ECOG≤1 (8%对25%) 患者的差异更为明显.

结论:

  • 使用MCB单独复合的HPN是一种安全有效的治疗方法.
  • MCB增强了患者自我管理HPN的能力,提高了独立性和安全性.
抽象的

No abstract available in PubMed .

关键词:
家庭亲肠道营养 家庭亲肠道营养通过多室袋单独复合营养.营养 营养 营养 营养 营养患者的自主权患者的自主权

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.1K

相关概念视频

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
148
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
324
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
715
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
320
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
871
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
517